Clinical Trials Directory

Trials / Sponsors / Regend Therapeutics

Regend Therapeutics

Industry · 10 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingTreatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
Chronic Obstructive Pulmonary Disease (COPD)
EARLY_Phase 12026-03-19
Not Yet RecruitingTreatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy
Idiopathic Pulmonary Fibrosis (IPF)
EARLY_Phase 12026-02-15
RecruitingA Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Phase 12026-01-08
RecruitingTreatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells
Pediatric Bronchiolitis Obliterans
EARLY_Phase 12025-11-11
CompletedA Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosi
Idiopathic Pulmonary Fibrosis
Phase 22023-12-11
CompletedTreatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell The
Chronic Obstructive Pulmonary Disease
Phase 22022-12-06
CompletedTreatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001
Idiopathic Pulmonary Fibrosis
Phase 12021-07-19
CompletedAutologous Bronchial Basal Cell Transplantation for Treatment of COPD
Chronic Obstructive Pulmonary Disease
Phase 1 / Phase 22018-06-12
UnknownAutologous Bronchial Basal Cells Transplantation for Treatment of CRD Including COPD, BE and PF
Chronic Respiratory Disease
EARLY_Phase 12017-04-05
UnknownAutologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis
Bronchiectasis
Phase 1 / Phase 22016-03-01